Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies
ClinicalTrials.gov study NCT04279405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT06905509. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)
ClinicalTrials.gov study NCT00754117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
ClinicalTrials.gov study NCT06559189. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT06180174. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy
ClinicalTrials.gov study NCT05725720. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04609241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06594939. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02653989. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04356846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
ClinicalTrials.gov study NCT06351527. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma
ClinicalTrials.gov study NCT04058470. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01087151. IPD Sharing: Not stated. Countries: 12. Publications: 0.
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT00788606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
ClinicalTrials.gov study NCT05823584. IPD Sharing: NO. Countries: 1. Publications: 0.
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04920617. IPD Sharing: Not stated. Countries: 10. Publications: 0.
CD19-CAR-T Cells in Patients With R/R B-ALL
ClinicalTrials.gov study NCT03574168. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
ClinicalTrials.gov study NCT02488512. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research
ClinicalTrials.gov study NCT06716164. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
ClinicalTrials.gov study NCT05797233. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.